UG Healthcare Corporation Limited

Catalist:8K7 Stock Report

Market Cap: S$74.9m

UG Healthcare Past Earnings Performance

Past criteria checks 0/6

UG Healthcare's earnings have been declining at an average annual rate of -23.8%, while the Medical Equipment industry saw earnings growing at 7.9% annually. Revenues have been declining at an average rate of 3.9% per year.

Key information

-23.8%

Earnings growth rate

-27.2%

EPS growth rate

Medical Equipment Industry Growth16.4%
Revenue growth rate-3.9%
Return on equity-5.4%
Net Margin-5.3%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How UG Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

Catalist:8K7 Revenue, expenses and earnings (SGD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24115-6320
31 Mar 24105-13300
31 Dec 2395-21270
30 Sep 2398-21270
30 Jun 23101-21270
31 Mar 23130-8530
31 Dec 2217111300
30 Sep 2220024400
30 Jun 2223337330
31 Mar 2226761400
31 Dec 2129685400
30 Sep 21327107400
30 Jun 21338119400
31 Mar 21305101180
31 Dec 2025067270
30 Sep 2018936180
30 Jun 2014413180
31 Mar 20118250
31 Dec 191032170
30 Sep 19982160
30 Jun 19923150
31 Mar 19873130
31 Dec 18834120
30 Sep 18805110
30 Jun 18784110
31 Mar 18733100
31 Dec 1771390
30 Sep 1768390
30 Jun 1765280
31 Mar 1762380
31 Dec 1660480
30 Sep 1659580
30 Jun 1659580
31 Mar 1661590
31 Dec 15614100
30 Sep 1558490
30 Jun 1556380
31 Mar 1552470
31 Dec 1448450
30 Sep 1449550
30 Jun 1449550

Quality Earnings: 8K7 is currently unprofitable.

Growing Profit Margin: 8K7 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 8K7 is unprofitable, and losses have increased over the past 5 years at a rate of 23.8% per year.

Accelerating Growth: Unable to compare 8K7's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 8K7 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-4.3%).


Return on Equity

High ROE: 8K7 has a negative Return on Equity (-5.44%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 21:47
End of Day Share Price 2024/12/18 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

UG Healthcare Corporation Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Khang Chuen OngCGS International
John CheongMaybank Research Pte. Ltd.
Paul ChewPhillip Securities Pte Ltd